Janone (ALTS) Stock Price, News & Analysis

Company Overview

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Key Stats

• Today's Range: $5.91 to $6.35
• 50-Day Range: $2.26 to $6.80
• 52-Week Range: $0.56 to $7.09
• Volume: 95,883 shs
• Average Volume: 282,499 shs
• Market Capitalization: $86.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALTS Stock Analysis - Frequently Asked Questions

How have ALTS shares performed this year?

Janone's stock was trading at $4.65 at the beginning of 2025. Since then, ALTS stock has increased by 31.8% and is now trading at $6.13.
View the best growth stocks for 2025 here.

How do I buy shares of Janone?

Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Janone own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Janone investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F).

Company Calendar

• Today: 2/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ALTS
• Previous Symbol: NASDAQ:ALTS
• CUSIP: N/A
• CIK: 862861
• Web: N/A
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,810,000.00
• Net Margins: N/A
• Pretax Margin: -312.94%
• Return on Equity: -2,940.01%
• Return on Assets: -39.81%

Debt

• Debt-to-Equity Ratio: 1.96
• Current Ratio: 0.75
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $39.61 million
• Price / Sales: 2.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.67) per share
• Price / Book: -9.10

Miscellaneous

• Outstanding Shares: 14,070,000
• Free Float: 13,380,000
• Market Cap: $85.74 million
• Optionable: N/A
• Beta: 1.89